Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)
Enovis (ENOV) posted quarterly Liabilities and Shareholders Equity of $3.8 billion for Q2 2026, down 21.39% year-over-year from $4.9 billion in Q2 2025, and little changed quarter-over-quarter from $3.8 billion in Q4 2025.
Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 21.39% year-over-year to $3.8 billion; the TTM figure through Apr 2026 stood at $17.1 billion (down 16.83% YoY), while the FY2025 annual figure was $3.8 billion, down 18.73% from the prior year.
- Liabilities and Shareholders Equity steadied at $3.8 billion in Q2 2026 per ENOV's latest filing, from $3.8 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $5.6 billion in Q3 2024 and bottomed at $1.8 billion in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $4.5 billion across 5 years, with a median of $4.4 billion in 2022.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 77.69% — and 2023, when it surged 138.87%.
- Enovis' Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then gained by 5.52% to $4.5 billion in 2023, then increased by 4.64% to $4.7 billion in 2024, then decreased by 18.73% to $3.8 billion in 2025, then slipped by 0.06% to $3.8 billion in 2026.
- Business Quant data shows ENOV's Liabilities and Shareholders Equity at $3.8 billion in Q2 2026, $3.8 billion in Q4 2025, and $4.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Enovis | 1.52 Bn | 1.50 Bn | 359.25 Mn | 3.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 3.77 Bn |
| Apr 3, 2026 | 3.83 Bn |
| Dec 31, 2025 | 3.83 Bn |
| Oct 3, 2025 | 4.43 Bn |
| Jul 4, 2025 | 5.02 Bn |
| Apr 4, 2025 | 4.88 Bn |
| Dec 31, 2024 | 4.72 Bn |
| Sep 27, 2024 | 5.55 Bn |
| Jun 28, 2024 | 5.44 Bn |
| Mar 29, 2024 | 5.48 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Sep 29, 2023 | 4.40 Bn |
| Jun 30, 2023 | 4.44 Bn |
| Mar 31, 2023 | 4.30 Bn |
| Dec 31, 2022 | 4.27 Bn |
| Sep 30, 2022 | 4.44 Bn |
| Jul 1, 2022 | 4.50 Bn |
| Apr 1, 2022 | 1.80 Bn |
| Dec 31, 2021 | 8.52 Bn |
| Oct 1, 2021 | 7.97 Bn |